BRIEF published on 04/22/2025 at 13:30, 1 day 7 hours ago Bausch Health dépose un supplément à sa circulaire de sollicitation de procurations suite aux échanges d'actions d'Icahn Droits Des Actionnaires Bausch Santé Swaps D'actions Carl Icahn Déclaration De Procuration
BRIEF published on 04/22/2025 at 13:30, 1 day 7 hours ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 1 day 7 hours ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 5 days 23 hours ago Bausch Health l'emporte devant un tribunal de district américain Bausch Santé Norwich Pharmaceuticals XIFAXAN® Décision De La FDA Exclusivité Teva
BRIEF published on 04/17/2025 at 21:45, 5 days 23 hours ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
PRESS RELEASE published on 04/17/2025 at 21:40, 5 days 23 hours ago U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Bausch Health and Salix Pharmaceuticals win U.S. District Court case against FDA regarding XIFAXAN, preserving patient access. Company to discuss financial results on April 30 FDA Financial Results Salix Pharmaceuticals XIFAXAN Bausch Health
BRIEF published on 04/14/2025 at 22:35, 8 days 22 hours ago Bausch Health adopte un plan de protection des droits des actionnaires Bausch Santé Approbation De La TSX Plan De Droits Des Actionnaires Protection Contre Les OPA Exigence De Ratification
BRIEF published on 04/14/2025 at 22:35, 8 days 22 hours ago Bausch Health Adopts Shareholder Rights Plan Bausch Health TSX Approval Shareholder Rights Plan Take-over Protection Ratification Requirement
PRESS RELEASE published on 04/14/2025 at 22:30, 8 days 22 hours ago Bausch Health Announces Adoption of Shareholder Rights Plan Bausch Health implements shareholder rights plan to safeguard fairness in take-over bids. Terms outlined for shareholder ratification within 6 months Bausch Health SRP Shareholder Rights Plan Take-over Bids Shareholder Ratification
BRIEF published on 04/10/2025 at 22:20, 12 days 22 hours ago Bausch Health Launches 2025 ASPIRE HIGHER Scholarship Program Bausch Health Higher Education Scholarship Program Dermatologic Conditions 2025 Initiative
Published on 04/23/2025 at 16:35, 4 hours 34 minutes ago Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025
Published on 04/23/2025 at 14:30, 6 hours 39 minutes ago EON Resources Inc. Reports Results for the Fiscal Year 2024 Position the Company for Future Growth
Published on 04/23/2025 at 14:22, 6 hours 47 minutes ago Films Using ReelTime's Reel Intelligence (RI) Eligible for Oscars Recognition
Published on 04/23/2025 at 14:00, 7 hours 9 minutes ago Pivotree to Release First Quarter 2025 Financial Results
Published on 04/23/2025 at 14:00, 7 hours 9 minutes ago MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation
Published on 04/23/2025 at 20:47, 21 minutes ago H2APEX receives shareholder loan and plans capital increase for further expansion of its hydrogen production capacities
Published on 04/23/2025 at 20:42, 26 minutes ago EQS-Adhoc: H2APEX Group SCA: Issuance of a Convertible Loan and a Comfort Letter; Planning of a Capital Increase
Published on 04/23/2025 at 20:03, 1 hour 5 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/23/2025 at 18:47, 2 hours 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/23/2025 at 18:23, 2 hours 45 minutes ago EQS-Adhoc: adidas brand momentum drives better-than-expected first quarter results
Published on 04/23/2025 at 18:39, 2 hours 30 minutes ago Derichebourg annonce son agenda financier pour l’exercice 2024/2025
Published on 04/23/2025 at 18:39, 2 hours 30 minutes ago Derichebourg announces its financial calendar for 2024/2025 financial year
Published on 04/23/2025 at 18:28, 2 hours 41 minutes ago Entech : Mise à disposition du rapport financier annuel 2024
Published on 04/23/2025 at 18:17, 2 hours 52 minutes ago Déclaration des transactions sur actions propres réalisées du 14 au 17 avril 2025
